KRAS and pancreatic neoplasm: Thus, overexpression of TSPAN6 in the two K-RAS-activating mutant human pancreatic cancer cell lines, PANC1 and MIA PaCa2, impaired proliferation and migration in vitro and significantly reduced tumor growth and metastasis in vivo.